Vaxcyte, Inc. - stock earnings
PCVX Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q4 | -180.8 million USD | ? USD |
| 2023Q3 | -92.7 million USD | ? USD |
| 2023Q2 | -68.3 million USD | ? USD |
| 2023Q1 | -48.4 million USD | ? USD |
| 2022Q4 | -93.4 million USD | ? USD |
| 2022Q3 | -57.3 million USD | ? USD |
| 2022Q2 | -49.2 million USD | ? USD |
| 2022Q1 | -38.8 million USD | ? USD |
| 2021Q4 | -28.6 million USD | ? USD |
| 2021Q3 | -26.6 million USD | ? USD |
| 2021Q2 | -23.7 million USD | ? USD |
| 2021Q1 | -21.2 million USD | ? USD |
| 2020Q4 | -20.7 million USD | ? USD |
| 2020Q3 | -21.0 million USD | ? USD |
| 2020Q2 | -20.3 million USD | ? USD |
| 2020Q1 | -27.1 million USD | ? USD |
| 2019Q4 | -14.6 million USD | ? USD |
| 2019Q3 | -11.3 million USD | ? USD |
| 2019Q2 | -10.7 million USD | ? USD |
| 2019Q1 | -13.7 million USD | ? USD |
PCVX Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -402.3 million USD | ? USD |
| 2022 | -239.6 million USD | ? USD |
| 2021 | -100.1 million USD | ? USD |
| 2020 | -87.8 million USD | ? USD |
| 2019 | -53.5 million USD | ? USD |
| 2018 | -29.5 million USD | ? USD |
| 2017 | -17.2 million USD | ? USD |
PCVX
Price: $60.55
52 week price:
Earnings Per Share: -4.14 USD
P/E Ratio: -15.82
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Volume: 346400
Market Capitalization: 6.7 billion